ACP: Improved Transparency Requires Reliable Data
Besides being transparent, any methodology used to publicly report price needs to contain adequate protections to ensure the reporting of reliable and valid price information, ACP recommended. In addition, price information provided to patients or consumers should be readily available and "presented in a manner that is easily understood and reflective of its limitations."
Price also should never be used as the "sole criterion for choosing a physician or any other healthcare professional." Price should only be considered along with the “explicit consideration” of the quality of services delivered and/or the effectiveness of the intervention, ACP noted.
For increasing the use of clinical performance transparency, ACP called for looking at clinical quality, resource use, and experience of care, which is the patient's view of care received from a provider.
- CDC Warns of Antibiotic Overuse in Hospitals
- Two-Midnight Rule Must be Fixed or Replaced, Say Providers
- Don't Underestimate Emotional Intelligence
- The Secret to Physician Engagement? It's Not Better Pay
- Care Coordination Tough to Define, Measure
- SCOTUS Review of NC Board Case 'A Very Big Deal' to Providers
- Yale New Haven Health Partners with Tenet Healthcare in CT
- Physicians Take SGR Repeal Message to Washington
- Size Matters in Antibiotic Overuse
- States with HIX Woes to Get Enrollment Relief